[artículo] 
inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 20-25

Título :	Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia
Tipo de documento:	texto impreso
Autores:	Donald E. Addington, Autor ; Jean Addington, Autor ; Scott B. Patten, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 20-25
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastorno Depresivo Mayor, Esquizofrenia, Psicología esquizofrénica, Sertralina.
Resumen:	The effectiveness of selective serotonin reuptake inhibitors for depression in remitted schizophrenia has not been clearly demonstrated. A randomized, double-blind, prospective placebo-controlled study was performed of 48 subjects meeting DSM-IV criteria for both schizophrenia in remission and for a major depressive episode.
Link:	./index.php?lvl=notice_display&id=31089

[artículo] Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia [texto impreso] / Donald E. Addington, Autor ; Jean Addington, Autor ; Scott B. Patten, Autor . - 2023 . - pp. 20-25.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 20-25

Palabras clave:	Trastorno Depresivo Mayor, Esquizofrenia, Psicología esquizofrénica, Sertralina.
Resumen:	The effectiveness of selective serotonin reuptake inhibitors for depression in remitted schizophrenia has not been clearly demonstrated. A randomized, double-blind, prospective placebo-controlled study was performed of 48 subjects meeting DSM-IV criteria for both schizophrenia in remission and for a major depressive episode.
Link:	./index.php?lvl=notice_display&id=31089